Tranexamic Acid Dosing Recommendations
Introduction to Tranexamic Acid Administration
- The American College of Cardiology and other guideline societies recommend administering tranexamic acid 1 gram IV over 10 minutes immediately, followed by 1 gram infused over 8 hours for trauma; for heavy menstrual bleeding, use 3.9 grams daily for up to 5 days during menstruation; and for surgical procedures, give 10-15 mg/kg bolus followed by 1-5 mg/kg/hour infusion 1, 2
Trauma and Acute Hemorrhage
- The critical window for tranexamic acid administration in trauma is within 3 hours of bleeding onset—beyond this timeframe, the drug may cause harm rather than benefit, with benefit decreasing by 10% for every 15-minute delay in administration 1
- Initial dose: 1 gram IV over 10 minutes, administered as soon as possible after bleeding begins, with a maintenance dose of 1 gram IV infused over 8 hours 1, 3
- Do not administer if more than 3 hours have elapsed since bleeding onset, as this increases risk of harm 1
Postpartum Hemorrhage
- First dose: 1 gram IV over 10 minutes for bleeding >500 mL after vaginal delivery or >1000 mL after cesarean section, with a second dose of 1 gram if bleeding continues after 30 minutes or restarts within 24 hours 1
- Administer early as part of standard treatment, not as rescue therapy when other measures fail 1
Surgical Procedures
- Loading dose: 10-15 mg/kg IV bolus, with a maintenance infusion of 1-5 mg/kg/hour 2
- The Horrow regimen (10 mg/kg followed by 1 mg/kg/hour) has been validated to achieve therapeutic plasma levels of 10 μg/mL needed to inhibit fibrinolysis 2
- Pediatric trauma dosing: 15 mg/kg loading dose followed by 2 mg/kg/hour infusion 4
Special Considerations
- History of thrombosis or thromboembolism is considered a contraindication in the United States, and avoid concomitant use with pro-thrombotic agents including Factor IX concentrates, anti-inhibitor coagulant concentrates, and hormonal contraceptives 1
- Delayed administration in trauma or postpartum hemorrhage reduces effectiveness; clinical diagnosis should suffice, and withholding second dose in postpartum hemorrhage if bleeding continues or recurs within 24 hours is not recommended 1